Login/Sign Up
Gpyrolon 0.2 mg Injection 1 ml belongs to the group of medications called 'anticholinergics' indicated in anaesthesia for reduction of airway or gastric secretions, volume and acidity of gastric secretions, and blockade of cardiac inhibitory reflexes during induction of anaesthesia and intubation, for protection against peripheral muscarinic effects of cholinergic agents, and intraoperatively to counteract surgically or drug-induced or vagal reflex associated arrhythmias. It is also used as adjunctive therapy for treating peptic ulcers.
Gpyrolon 0.2 mg Injection 1 ml contains 'Glycopyrrolate', which works by inhibiting the action of acetylcholine. Thus, reduces gastric secretions' volume and free acidity and controls excessive pharyngeal, bronchial, and tracheal secretions.
Gpyrolon 0.2 mg Injection 1 ml will be administered by a healthcare professional; do not self-administer. In some cases, Gpyrolon 0.2 mg Injection 1 ml may cause dry mouth, urinary retention and hesitancy, blurred vision, palpitations, and decreased sweating. Most of these side effects of Gpyrolon 0.2 mg Injection 1 ml do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.
Inform your doctor if you are allergic to any components in Gpyrolon 0.2 mg Injection 1 ml. Consult your doctor if you are pregnant or breastfeeding. Gpyrolon 0.2 mg Injection 1 ml may cause drowsiness and blurred vision, do not drive or operate machinery unless you are alert. Let your doctor know if you are taking prescription and non-prescription medications, including vitamins and herbal supplements.
Gpyrolon 0.2 mg Injection 1 ml belongs to the group of medications called 'anticholinergics' indicated in anaesthesia for reduction of airway or gastric secretions, volume and acidity of gastric secretions, and blockade of cardiac inhibitory reflexes during induction of anaesthesia and intubation, intraoperatively to counteract surgically or drug-induced or vagal reflex associated arrhythmias, and for protection against peripheral muscarinic effects of cholinergic agents. It is also used as adjunctive therapy for treating peptic ulcers when an immediate anti-cholinergic effect is desired or oral medication is not feasible. Gpyrolon 0.2 mg Injection 1 ml contains 'Glycopyrrolate', which works by inhibiting the action of acetylcholine. Thus, reduces gastric secretions' volume and free acidity and controls excessive pharyngeal, bronchial, and tracheal secretions.
Do not take Gpyrolon 0.2 mg Injection 1 ml if you are allergic to any components. Inform your doctor if you have glaucoma, gastrointestinal obstruction, obstructive uropathy, paralytic ileus (intestinal obstruction), debilitated (weak), severe/complicated ulcerative colitis, toxic megacolon, myasthenia gravis (muscle problems), coronary artery disease, cardiac arrhythmia, congestive heart failure, high blood pressure, hyperthyroidism, kidney or liver problems. Consult your doctor if you are pregnant or breastfeeding. Keep your doctor informed about your health condition and medications to rule out any interactions/side effects.
Drug-Drug Interactions: Gpyrolon 0.2 mg Injection 1 ml may interact with other anticholinergics or drugs with anticholinergic activity, such as antiparkinson drugs, phenothiazines, tricyclic antidepressants, and electrolyte supplements (potassium chloride).
Drug-Food Interactions: No interactions found/established.
Drug-Disease Interactions: Inform your doctor if you have glaucoma, gastrointestinal obstruction, obstructive uropathy (hindrance of normal urine flow), paralytic ileus (intestinal obstruction), debilitated (weak), severe/complicated ulcerative colitis, toxic megacolon (a complication of severe colon disease or infection), or myasthenia gravis (muscle problems).
Peptic ulcers:
Peptic ulcers: Peptic ulcers are sores that develop on the lining of the stomach and intestine due to erosion of the stomach's protective lining. Symptoms include nausea, changes in appetite, bloody or dark stools, unexplained weight loss, vomiting, and indigestion.
About Gpyrolon 0.2 mg Injection 1 ml
Gpyrolon 0.2 mg Injection 1 ml belongs to the group of medications called 'anticholinergics' indicated in anaesthesia for reduction of airway or gastric secretions, volume and acidity of gastric secretions, and blockade of cardiac inhibitory reflexes during induction of anaesthesia and intubation, for protection against peripheral muscarinic effects of cholinergic agents, and intraoperatively to counteract surgically or drug-induced or vagal reflex associated arrhythmias. It is also used as adjunctive therapy for treating peptic ulcers.
Gpyrolon 0.2 mg Injection 1 ml contains 'Glycopyrrolate', which works by inhibiting the action of acetylcholine. Thus, reduces gastric secretions' volume and free acidity and controls excessive pharyngeal, bronchial, and tracheal secretions.
Gpyrolon 0.2 mg Injection 1 ml will be administered by a healthcare professional; do not self-administer. In some cases, Gpyrolon 0.2 mg Injection 1 ml may cause dry mouth, urinary retention and hesitancy, blurred vision, palpitations, and decreased sweating. Most of these side effects of Gpyrolon 0.2 mg Injection 1 ml do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.
Inform your doctor if you are allergic to any components in Gpyrolon 0.2 mg Injection 1 ml. Consult your doctor if you are pregnant or breastfeeding. Gpyrolon 0.2 mg Injection 1 ml may cause drowsiness and blurred vision, do not drive or operate machinery unless you are alert. Let your doctor know if you are taking prescription and non-prescription medications, including vitamins and herbal supplements.
₹13.5*
MRP ₹15
10% off
₹12.75*
MRP ₹15
15% CB
₹2.25 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Online payment accepted
Provide Delivery Location
Whats That
Online payment accepted
Product Substitutes
Uses of Gpyrolon 0.2 mg Injection 1 ml
Medicinal Benefits
Gpyrolon 0.2 mg Injection 1 ml belongs to the group of medications called 'anticholinergics' indicated in anaesthesia for reduction of airway or gastric secretions, volume and acidity of gastric secretions, and blockade of cardiac inhibitory reflexes during induction of anaesthesia and intubation, intraoperatively to counteract surgically or drug-induced or vagal reflex associated arrhythmias, and for protection against peripheral muscarinic effects of cholinergic agents. It is also used as adjunctive therapy for treating peptic ulcers when an immediate anti-cholinergic effect is desired or oral medication is not feasible. Gpyrolon 0.2 mg Injection 1 ml contains 'Glycopyrrolate', which works by inhibiting the action of acetylcholine. Thus, reduces gastric secretions' volume and free acidity and controls excessive pharyngeal, bronchial, and tracheal secretions.
Side Effects of Gpyrolon 0.2 mg Injection 1 ml
Directions for Use
Storage
Drug Warnings
Do not take Gpyrolon 0.2 mg Injection 1 ml if you are allergic to any components. Inform your doctor if you have glaucoma, gastrointestinal obstruction, obstructive uropathy, paralytic ileus (intestinal obstruction), debilitated (weak), severe/complicated ulcerative colitis, toxic megacolon, myasthenia gravis (muscle problems), coronary artery disease, cardiac arrhythmia, congestive heart failure, high blood pressure, hyperthyroidism, kidney or liver problems. Consult your doctor if you are pregnant or breastfeeding. Keep your doctor informed about your health condition and medications to rule out any interactions/side effects.
Therapeutic Class
Drug-Drug Interactions Checker List
Diet & Lifestyle Advise
Peptic ulcers:
Habit Forming
Disease/Condition Glossary
Peptic ulcers: Peptic ulcers are sores that develop on the lining of the stomach and intestine due to erosion of the stomach's protective lining. Symptoms include nausea, changes in appetite, bloody or dark stools, unexplained weight loss, vomiting, and indigestion.